Showing results (21-30 of 179) with videos related to
Sort By:
Pageof 18
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.British Journal of Haematology|April 1, 1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbitsS Saivin, C Caranobe, M Petitou, et al.The Journal of Laboratory and Clinical Medicine|January 1, 1990
Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfateF Dol, M Petitou, J C Lormeau, et al.Thrombosis and Haemostasis|December 7, 1992
Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbitD Carrie, C Caranobe, A M Gabaig, et al.Lancet (London, England)|August 24, 1985
Constitutional heparin co-factor II deficiency associated with recurrent thrombosisP Sie, D Dupouy, J Pichon, et al.Thrombosis Research|September 15, 1987
Inactivation of heparin cofactor II by polymorphonuclear leukocytesP Sie, D Dupouy, F Dol, et al.British Journal of Haematology|November 1, 1983
Platelet density analysis: a tool for the detection of acquired storage pool disease in manB Boneu, P Sié, N Eche, et al.Thrombosis Research|April 1, 1989
Neutralization of dermatan sulfate in vitro and in vivo by protamine sulfate and polybreneP Sié, B Cremers, D Dupouy, et al.Thrombosis and Haemostasis|July 29, 1984
Abnormal platelet serotonin uptake and binding sites in myeloproliferative disordersC Caranobe, P Sié, F Fernandez, et al.Thrombosis and Haemostasis|June 28, 1982
Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathyP Sié, E Letrenne, C Caranobe, et al.Pageof 18